Latest Regulatory News

Uscom Limited reported a 27% drop in cash reserves for Q1 2025, driven by declining revenue and rising costs, while preparing to sell its main business unit to stabilize finances.

Electro Optic Systems (EOS) reports a surge in contract backlog to $415 million, anchored by a landmark $125 million export order for a high-energy laser weapon. Despite a $34.3 million operating cash outflow in Q3, EOS is poised for growth with new defence contracts and product innovations.

Citigold Corporation continues its efforts to restart the high-grade Charters Towers Gold Project, focusing on exploration, mine design, and securing funding despite a significant annual loss.

Emperor Energy has secured a significant resource upgrade for its Judith Gas Field and raised $3.7 million to progress the Judith-2 appraisal well, targeting commercial gas supply in a tightening East Coast market.

Blue Energy has been granted a critical petroleum lease in Queensland and completed a $5.8 million capital raise, positioning itself to meet rising gas demand aligned with the Queensland Government’s new Energy Roadmap.

Clarity Pharmaceuticals has bolstered its financial position with a $203 million institutional placement and reported positive Phase II trial results for its lead prostate cancer diagnostic, Cu-SAR-bisPSMA. The company also expanded its pipeline with promising preclinical data on a pan-cancer agent and secured a key copper-67 supply agreement to support future commercialisation.

The Star Entertainment Group reported a 5% revenue increase in Q1 FY26 and a halving of its EBITDA loss, while navigating regulatory challenges and advancing a major joint venture exit.

Kingsrose Mining advances exploration in Norway’s Finnmark region with new geophysical anomalies, while navigating permitting challenges in Finland and focusing on strategic M&A under new leadership.

The Treasurer has expressed preliminary concerns that Cosette Pharmaceuticals’ proposed acquisition of Mayne Pharma could harm Australia’s economy, citing plans to close a key Adelaide manufacturing site. Mayne Pharma disputes these claims and urges a resolution before the scheme deadline.

Memphasys has sharpened its commercial focus on the Felix™ System, securing a major distribution expansion in the MENA region and cutting operational costs by 40%, setting the stage for a global market push.

Energy Transition Minerals Ltd has acquired the Penouta tin-tantalum-niobium mine in Spain at a significant discount, raised A$18 million in capital, and received a key arbitration ruling on its Greenland rare earths project.

Aeris Resources has announced a significant $90 million equity raise through a placement and share purchase plan, aiming to strengthen its balance sheet and fund key growth projects. The raise comes with a discount to recent share prices and supports the company’s strategic expansion and operational improvements.